Skip to main content

Table 2 Hemodynamic indices

From: Type 2 diabetes compromises the value of non-invasively measured augmentation index in predicting the severity of coronary artery disease: a hospital-based observational study

 

Total

(n = 197)

Non-diabetic

(n = 113)

Diabetic

(n = 84)

p-value

SBP(mmHg)

130.1 ± 17.3

127.8 ± 17.5

133.2 ± 16.6

0.037*

DBP(mmHg)

74.9 ± 11.1

74.8 ± 10.9

75.0 ± 11.5

0.884

CASP(mmHg)

120.3 ± 16.6

118.1 ± 16.5

123.1 ± 16.5

0.044*

MAP(mmHg)

91.9 ± 12.1

91.3 ± 12.8

92.8 ± 11.2

0.387

AP(mmHg)

11.8 ± 7.5

11.9 ± 7.3

11.7 ± 7.9

0.840

Central PP(mmHg)

45.4 ± 13.0

43.5 ± 11.9

48.1 ± 13.9

0.130

Brachial PP(mmHg)

55.2 ± 14.0

53.2 ± 13.2

58.1 ± 14.5

0.130

PR(bpm)

67.7 ± 10.1

67.5 ± 10.3

67.8 ± 9.8

0.750

AIx(%)

77.8 ± 14.5

77.0 ± 14.0

79.0 ± 15.0

0.372

AIx@75(%)

74.9 ± 14.2

74.0 ± 14.3

76.1 ± 13.9

0.317

PRT(ms)

114.5 ± 27.0

116.1 ± 28.1

112.5 ± 25.4

0.374

  1. *p value for comparison between the non-diabetic and diabetic groups; p < 0.05 indicates statistical significance. SBP systolic blood pressure, DBP diastolic blood pressure, MAP mean arterial pressure, PP pulse pressure, PR pulse rate, CASP central aortic systolic pressure, AP augmentation pressure, PRT peak relative time